Comparison of minimal residual disease detection in multiple myeloma between the DuraClone and EuroFlow methods.

Yoroidaka T, Narita K, Takamatsu H, Fujisawa M, Nakao S, Matsue K

Open source

DOI
10.1038/s41598-021-89761-9
Published
2021 May 27
Container
Scientific reports
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-021-89761-9,
  title = {Comparison of minimal residual disease detection in multiple myeloma between the DuraClone and EuroFlow methods.},
  author = {Yoroidaka T and Narita K and Takamatsu H and Fujisawa M and Nakao S and Matsue K},
  year = {2021},
  journal = {Scientific reports},
  doi = {10.1038/s41598-021-89761-9},
  url = {https://doi.org/10.1038/s41598-021-89761-9}
}

RIS

TY  - JOUR
TI  - Comparison of minimal residual disease detection in multiple myeloma between the DuraClone and EuroFlow methods.
AU  - Yoroidaka T
AU  - Narita K
AU  - Takamatsu H
AU  - Fujisawa M
AU  - Nakao S
AU  - Matsue K
PY  - 2021
JO  - Scientific reports
DO  - 10.1038/s41598-021-89761-9
UR  - https://doi.org/10.1038/s41598-021-89761-9
ER  -

APA

T, Y., K, N., H, T., M, F., S, N., & K, M. (2021). Comparison of minimal residual disease detection in multiple myeloma between the DuraClone and EuroFlow methods.. Scientific reports. https://doi.org/10.1038/s41598-021-89761-9

Source records